Atlas Trials

The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma

Clinical trial NCT03652467 · UNKNOWN

Trial details

NCT number
NCT03652467
Sponsor
Jinan Military General Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma Non-resectable
Start date
2018-09-01
Primary completion
2022-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.